Erectile dysfunction drugs market dynamics, business overview, share value and covid 19 impact analysis by 2023

1. Erectile Dysfunction Drugs Market Dynamics, Business Overview, Share
Value and COVID-19 Impact Analysis By 2023
Competitive Analysis:
Leading players in the global erectile dysfunction drugs market include Apricus
Biosciences Inc., S.K. Chemicals Co. Ltd., Dong-A Pharmaceutical Co. Ltd., Eli Lilly &
Co., Bayer AG, and Pfizer Inc.
Seoul Pharmaceutical announced plans to export Sildenafil 50mg and 100mg and Tadalafil
20mg to Taiwanese company Ryders International for the next five years. This is a key step
in Seoul’s efforts to branch out into the Asian market for ED drugs. The company also
exported Aliden suspension to Mongolia in April 2019, as well as receiving sales approval
for Sildenafil in Indonesia in August.
Regional Analysis:
The Americas are likely to retain the top position in the global erectile dysfunction drugs
market over the forecast period thanks to the presence of several leading players in the
global erectile dysfunction drugs market, which has allowed for easy and widespread
distribution of a number of erectile dysfunction drugs. Europe holds the second largest
share in the global erectile dysfunction drugs market, followed by Asia Pacific.
Overview
The global erectile dysfunction drugs market size was valued USD 1.65 billion in 2016 and
is expected to reach a valuation of USD 2.95 billion at a CAGR of 6.5% by 2023, says
Market Research Future (MRFR). Erectile dysfunction drugs are drugs used to correct
erectile dysfunction, i.e. the inability of men to hold an erection and conceive. The growing
awareness about erectile dysfunction is the major driver for the global erectile dysfunction
drugs market, as people who would otherwise have been too ashamed to purchase ED
products are now buying them openly. Increasing marketing efforts from developers of
erectile dysfunction drugs to promote their products are also a major factor in the global
erectile dysfunction drugs market exhibiting robust growth in the last few years. Growing
awareness about erectile dysfunction drugs is likely to remain a key driver for the global
erectile dysfunction drugs market over the forecast period.
The global erectile dysfunction drugs market is analyzed comprehensively in the report,
which includes a detailed assessment of the major drivers and restraints affecting the
market’s growth as well as key indicators regarding the economic background of the
market. Microeconomic and macroeconomic factors affecting the global erectile
dysfunction drugs market are analyzed in the report to provide a comprehensive look into
the factors making the erectile dysfunction drugs market tick.

2. Request Free Sample Copy:
https://www.marketresearchfuture.com/sample_request/1313
Increasing manufacturing of generic erectile dysfunction drugs as well as the increasing
availability of counterfeit erectile dysfunction drugs is likely to remain the key restraint on
the global erectile dysfunction drugs market over the forecast period. Due to the patent
expiry of blockbuster drugs, many generic variants are coming into the market, usually at
lower prices than the former. This is likely to eat into the prospects of the erectile
dysfunction drugs market in the coming years, with consumers often preferring lower
priced generic variants of erectile dysfunction drugs than more expensive blockbuster
varieties.
Counterfeiting is also likely to be a major problem for the global erectile dysfunction drugs
market, due to the lucrative marketing of counterfeit erectile dysfunction drugs at much
lower prices than either patented or generic drugs. In August 2019, a Southern California
man was sentenced to more than eight years in prison for illegally smuggling erectile
dysfunction products from China. Such cases are likely to remain a key threat for the global
erectile dysfunction drugs market over the forecast period.
Erectile Dysfunction Drugs Market Segmentation:
The global erectile dysfunction drugs market is segmented based on product, end use, and
region.
By product, the global erectile dysfunction drugs market is segmented into Viagra, Cialis,
Levitra, Stendra, Zydena, and others. Viagra holds a dominant 40% share in the global
erectile dysfunction drugs market, with Levitra and Cialis also holding significant shares in
the market. This configuration of the market is likely to sustain in the coming years, despite
the patent expiry concerns regarding Viagra and the subsequent onslaught of generics.
By end use, the global erectile dysfunction drugs market is segmented into hospitals,
clinics, pharmaceutical companies, and others.
Browse Full Research Report
at: https://www.marketresearchfuture.com/reports/erectile-dysfunction-drugs-
market-1313
Erectile Dysfunction Drugs Market Drivers and Impact
• Rising Demand from Key Regions
• Growing Demand from Key Applications and Potential Industries
• Erectile Dysfunction Drugs Market Challenges and Impact
• Key Factors Considered for Industry Growth
• Erectile Dysfunction Drugs Market Trends and Application

3. Browse Related Reports at:
Fertility Drug and Surgery Market | Therapeutics, Size and Growth Forecast To 2023
Surgical Site Infection Control Market Overview, Growth, Trends, by 2023
Cell Therapy Market Growth, Size, Trends, Report Analysis, Forecast to 2023
Cardiac Implants Market - Industry Size, Share, Analysis, Trends and Forecast by 2023 |
MRFR
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity
of various industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients.